Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help expedite their drug candidates to market. Regis has the necessary technical and operational capabilities to fully support its clients' preclinical and clinical API needs. We offer a full range of services to support the development of our clients' lead molecules through commercialization, including process research and development, analytical development, impurity isolation and characterization, stability services, GMP API manufacturing,  solid state chemistry, and high potent API manufacturing . With extensive organic expertise and collegiate collaborations, we also offer an innovative line of proprietary chromatography products sold throughout the world. Regis is privately owned and operated and has been in business in the Chicagoland area since 1956.

Sales Markets

Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Primary business activity

Contract Service; Manufacturer/Innovator

Contact information

Address

Telephone

Website

View All Contact Info

Top Products

(R)-(-)-MTPA-Cl

Regis Technologies Inc.

Request Info

(R)-(-)-MTPA-Cl

Regis Technologies Inc.

Request Info

(R)-(-)-MTPA-Cl

Regis Technologies Inc.

Request Info

Our Resources

Categories affiliated with Regis Technologies Inc.